Myomo, Inc. announced it has entered into its first contracts that will allow the MyoPro to be provided to patients covered by private insurance on an in-network basis. This development is expected to expand access to the MyoPro device for individuals suffering from neurological disorders and upper-limb paralysis.
Securing in-network status with private payers is a significant step for Myomo. It streamlines the reimbursement process for a broader patient population, potentially increasing the adoption rate of the MyoPro device.
This strategic move complements the existing Medicare Part B coverage, further solidifying Myomo's reimbursement landscape and market reach.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.